The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan.
FIB-4 index
liver fibrosis
nonalcoholic fatty liver disease
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
19 Oct 2020
19 Oct 2020
Historique:
received:
02
09
2020
revised:
07
10
2020
accepted:
19
10
2020
entrez:
22
10
2020
pubmed:
23
10
2020
medline:
23
10
2020
Statut:
epublish
Résumé
In patients with nonalcoholic fatty liver disease (NAFLD), liver fibrosis is the predictive factor for liver-related events and prognosis. This retrospective study aimed to evaluate longitudinal changes in the FIB-4 index and to determine a strategy for diagnosing and following patients with NAFLD using this index. We analyzed the FIB-4 index at baseline and after 1 and 5 years in 272 consecutive patients with biopsy-proven NAFLD. Of these, 52 patients underwent serial biopsies. The change in the FIB-4 index was correlated with changes in the fibrosis stage among these patients (
Identifiants
pubmed: 33086582
pii: diagnostics10100842
doi: 10.3390/diagnostics10100842
pmc: PMC7603133
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Hepatol. 2019 Sep - Oct;18(5):736-741
pubmed: 31054978
Liver Int. 2019 May;39(5):924-932
pubmed: 30253043
Gastroenterology. 2015 Aug;149(2):389-97.e10
pubmed: 25935633
J Hepatol. 2005 Jan;42(1):132-8
pubmed: 15629518
J Gastroenterol. 2018 Feb;53(2):181-196
pubmed: 29177681
Aliment Pharmacol Ther. 2013 Jul;38(2):134-43
pubmed: 23718573
Hepatology. 2012 Jun;55(6):2005-23
pubmed: 22488764
Hepatology. 2006 Oct;44(4):865-73
pubmed: 17006923
Gastroenterology. 2005 Jun;128(7):1898-906
pubmed: 15940625
J Hepatol. 2015 Jul;63(1):237-64
pubmed: 25911335
Microorganisms. 2020 Feb 29;8(3):
pubmed: 32121404
N Engl J Med. 2001 Feb 15;344(7):495-500
pubmed: 11172192
Clin Gastroenterol Hepatol. 2015 Apr;13(4):643-54.e1-9; quiz e39-40
pubmed: 24768810
Hepatol Res. 2015 Mar;45(3):269-78
pubmed: 24796231
Diabetes Care. 2010 Feb;33(2):284-6
pubmed: 19880582
Am J Gastroenterol. 2008 Jul;103(7):1682-8
pubmed: 18616651
Hepatol Res. 2017 Oct;47(11):1206-1211
pubmed: 27917557
Clin Gastroenterol Hepatol. 2009 Apr;7(4):481-6
pubmed: 19162235
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Hepatology. 2009 Mar;49(3):1017-44
pubmed: 19243014
PLoS One. 2015 Oct 20;10(10):e0140427
pubmed: 26485523
Clin Gastroenterol Hepatol. 2009 Oct;7(10):1104-12
pubmed: 19523535
Hepatol Commun. 2019 Jul 29;3(10):1322-1333
pubmed: 31592044
Ann Hepatol. 2020 Jul - Aug;19(4):380-387
pubmed: 32451205
J Hepatol. 2013 Sep;59(3):550-6
pubmed: 23665288
J Gastroenterol. 2018 Mar;53(3):438-448
pubmed: 28744823
Gut. 2010 Jul;59(7):969-74
pubmed: 20581244
BMC Gastroenterol. 2012 Jan 05;12:2
pubmed: 22221544
J Hepatol. 2009 Aug;51(2):371-9
pubmed: 19501928
Hepatology. 2004 Oct;40(4):820-6
pubmed: 15382171
Hepatol Res. 2015 Oct;45(10):E53-61
pubmed: 25429984
J Gastroenterol. 2018 Jan;53(1):140-151
pubmed: 28669071
J Hepatol. 2015 Sep;63(3):705-12
pubmed: 25980762
Gastroenterology. 2016 Mar;150(3):626-637.e7
pubmed: 26677985